KEMWELL BIOPHARMA PRIVATE LIMITED is a biologics-focused Contract Development and Manufacturing (CDMO) company that provides essential services to global biopharmaceutical organisations. With facilities located in Bangalore, India, Kemwell’s operations are supported by advanced technology from a leading German biopharma company. The company offers mammalian cell culture-based product development and cGMP manufacturing services for both drug substances and drug products. Their facility is equipped with a cGMP drug substance manufacturing area featuring over 5000L bioreactor capacity, sterile fill and finish areas for cGMP drug product manufacturing, and process development laboratories to support the production of protein therapeutics such as monoclonal antibodies, bi-specific antibodies, and fusion proteins.

Services include:
– Contract development and manufacturing of biologics
– cGMP drug substance manufacturing
– cGMP drug product manufacturing
– Sterile fill and finish services
– Process development for protein therapeutics
– Mammalian cell culture-based product development

KEMWELL BIOPHARMA PRIVATE LIMITED continues to be a significant player in the biopharmaceutical industry, providing high-quality services that meet the stringent requirements of their clients. For more information, please visit kemwellpharma.com.